2Pauwels R, Buist S, Calverly P, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med, 2001,163(5): 1257-1276.
3Davies L,Angus R,Calverley P. Oral corticosteroids in patients admitted to hospital with exacerbations of COPD: a prospective randomized controlled trial. Lancet,1999,354(9177):456-460.
4Niewoehner D,Erbland M,Deupree R, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med, 1999,340(25) :1941-1947.
5Nishimura K, Ikeda A, Koyama H, et al. Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease. Pulm Pharmacol Ther,2000,13(5) :225-230.
6Pauwels R, Lofdahl C, Laitinen L, et al. Long term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med, 1999,340(25): 1948-1953.
7Vestbo J,Sorensen T,Lange P,et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease:A randomized controlled trial. Lancet,1999,353(9167):1819-1823.
8The Lung Health Research Group. Effect of inhaler triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med, 2000, 343 (26):1902-1909.
9Burge P,Calverley P,Jones P,et al. Randomized,double blind,placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease:the ISOLDE trial. Brit Med J, 2000,320(7245): 1297-1303.
10Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomized controlled trial. Lancet, 2003,361(9356) :449-456.
